Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study
Open Access
- 30 April 2024
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 24 (1) , 1-10
Abstract
Background: Bone metastasis (BM) carries a poor prognosis for patients with upper-tract urothelial carcinoma (UTUC). This study aims to identify survival predictors and develop a prognostic nomogram for overall survival (OS) in UTUC patients with BM. Methods: The Surveillance, Epidemiology, and End Results database was used to select patients with UTUC between 2010 and 2019. The chi-square test was used to assess the baseline differences between the groups. Kaplan–Meier analysis was employed to assess OS. Univariate and multivariate analyses were conducted to identify prognostic factors for nomogram establishment. An independent cohort was used for external validation of the nomogram. The discrimination and calibration of the nomogram were evaluated using concordance index (C-index), area under receiver operating characteristic curve (AUC), calibration curve, and decision curve analysis (DCA). All statistical analyses were performed using SPSS 23.0 and R software 4.2.2. Results: The mean OS for UTUC patients with BM was 10 months (95% CI: 8.17 to 11.84), with 6-month OS, 1-year OS, and 3-year OS rates of 41%, 21%, and 3%, respectively. Multi-organ metastases (HR = 2.21, 95% CI: 1.66 to 2.95, P < 0.001), surgery (HR = 0.72, 95% CI: 0.56 to 0.91, P = 0.007), and chemotherapy (HR = 0.37, 95% CI: 0.3 to 0.46, P < 0.001) were identified as independent prognostic factors. The C-index was 0.725 for the training cohort and 0.854 for the validation cohort, and all AUC values were > 0.679. The calibration curve and DCA curve showed the accuracy and practicality of the nomogram. Conclusions: The OS of UTUC patients with BM was poor. Multi-organ metastases was a risk factor for OS, while surgery and chemotherapy were protective factors. Our nomogram was developed and validated to assist clinicians in evaluating the OS of UTUC patients with BM.Keywords
Funding Information
- Medical Scientific Research Projects of Zhejiang Province (2024KY306)
- Ningbo Top Medical and Health Research Program (2022020203, 2022020203)
This publication has 30 references indexed in Scilit:
- Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature reviewHeliyon, 2023
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateEuropean Urology, 2023
- The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinomaCancer Medicine, 2021
- Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic TherapyEuropean Urology, 2021
- External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracyJournal of Bone Oncology, 2021
- A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysisCancer Communications, 2020
- Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial CarcinomaEuropean Urology, 2017
- Skeletal-related events and prognosis in urothelial cancer patients with bone metastasisInternational Journal of Clinical Oncology, 2017
- A contemporary review of management and prognostic factors of upper tract urothelial carcinomaCancer Treatment Reviews, 2015
- Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative ChemotherapyEuropean Urology, 2010